State-of-the-art AI programs can support the development of drugs by predicting how proteins interact with small molecules.
Virtual screening methods fall broadly into two categories: ligand- and structure-based. Ligand-based virtual screening doesn’t require a target protein structure, Instead, it leverages known active ...
The traditional office layout like rows of cubicles, rigid desk assignments, and windowless meeting rooms is rapidly becoming ...
The research highlights that energy–food market connectedness is highly crisis-sensitive, expanding dramatically during ...
A segment of ultra-fast fashion moves products from design to market within days, releases thousands of new items weekly, and ...
New research reveals how tiny electrical gates in the brain, known as NMDA receptors, control learning, memory, and neuron ...
Wondering which retro design trends are coming back? Designers say bold wallpaper choices and vintage items are about to be ...
An artificial intelligence model predicts how brain immune cells react to RNA and DNA nanoparticles, helping scientists design safer and more effective nucleic acid therapies faster.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback